Press release
Number of shares and votes in Oncopeptides
STOCKHOLM – June 28, 2024 – Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that the number of votes in Oncopeptides has changed as a result of a conversion of 238,107 class C shares in Oncopeptides to a total 238,107 ordinary shares, in order to deliver ordinary shares to participants in Oncopeptides’ incentive program Board SHP 2023.
As of today, the total number of shares in Oncopeptides amounts to 215,186,246 shares, of which 211,263,903 are ordinary shares and 3,922,343 are class C shares. As of today, the number of votes in Oncopeptides amounts to 211,656,137.19, and the share capital amounts to SEK 23,909,583.859895.